Prediabetes in End Stage Renal Disease on Dialysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

262 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-13

Study Completion Date

2025-10-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prediabetes is a highly prevalent condition, affecting about one-third of adults in the United States Patients with prediabetes have an increased risk for diabetes, with 2% to 10% progressing to diabetes each yea Although prediabetes is frequently considered an intermediary stage in the progression between normoglycemia and diabetes, many individuals may have prediabetes for several years, while some may never progress.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy

NCT05695573

Diabetic Nephropathy

COMPLETED

Oxygen Therapy in Diabetic Kidney Disease

NCT06959485

Diabetic Kidney Disease

NOT_YET_RECRUITING NA

Lipid Profile in Diabetic and Non Diabetic CKD Patients

NCT06802978

Chronic Kidney Disease Patients

RECRUITING

SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?

NCT04853615

SGLT2i Kideny Protection Against Contrast in Diabetic Kidney

UNKNOWN

Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

NCT02981966

Diabetes Mellitus, Type 2

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Screening Pre Diabetic Chronic Renal Failure (CRF) Dialysis Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* End stage renal disease on dialysis patients aged ≥ 18 years old.

Exclusion Criteria

1. Patients previously diagnosed with prediabetes.
2. Patients previously diagnosed with diabetes mellitus.
3. Acute Medical Status :Hospitalized patients.
4. Physiological States: Pregnant females.Lactating females.
5. Specific Comorbidities \& Conditions: Polycystic kidney disease.
6. New York Heart Association (NYHA) class III or IV heart failure.
7. Known liver cirrhosis. or HIV/AIDS.
8. Renal cancer.
9. Active immunosuppression. or Recent chemotherapy or immunosuppressive therapy.
10. History of organ transplantation.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No